Please note: This trial has finished recruiting and is not accepting new participants.

Research Center: Texas Center for Drug Development, Inc.
Location: 6550 Mapleridge Street, Suite 201, Houston, TX 77081

Background

Human papillomavirus or HPV is a very common sexually transmitted disease. Research shows that oral infection of this virus can pose a risk in developing head and neck cancer which accounts for 4% of all cancers in the United States.

An HPV vaccine is currently being tested to find out if it can lower the chance of getting mouth infection caused by some types of Human Papillomavirus (HPV) compared to placebo (a look alike with no active ingredients). 

This study seeks healthy men. Participants are required to attend 10 study visits at the research site over a 3 and a half-year period and will be compensated up to $1,200 for participating in this study.

Why Participate? 

• You may lower your chance of getting mouth infection caused by HPV.
• You will be compensated for participating in this study for your time & travel to the research site.
• You will be helping to advance medical research. 

Your Rights

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

• Healthy men more than 18 years of age
• Able to attend study visits at the research site 
• Is sexually Active